Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

NCT07140679 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Localized Colon Carcinoma
Stage IIB Colon Cancer AJCC v8
Stage IIC Colon Cancer AJCC v8
Stage III Colon Cancer AJCC v8

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Colonoscopy
PROCEDURE: Computed Tomography
OTHER: Questionnaire Administration
DRUG: Toripalimab

Sponsor

Emory University

Collaborators

[object Object]
[object Object]